Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation by Confocal Reflectance Microscopy of the Skin Structure of Patients With Atopic Dermatitis Treated With Tralokinumab Biotherapy.

NCT07568665 is registered in ClinicalTrials.gov with Hôpitaux Drôme Nord as lead sponsor.

NCT NCT07568665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07568665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation by Confocal Reflectance Microscopy of the Skin Structure of Patients With Atopic Dermatitis Treated With Tralokinumab Biotherapy.
Lead sponsor
Hôpitaux Drôme Nord
Phase
Observational
Overall status
Active, not recruiting
Start date
November 27, 2025
Completion date
November 1, 2028
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis (ad), atopic dermatitis (eczema)